PURPOSE: Delivery of hydrophobic compounds to the retina/RPE has been challenging. The purpose of this study was to develop an effective method for the sustained delivery of retinoids to rod and cone photoreceptors of young mice lacking a normal supply of 11-cis retinal. METHODS: Solubilized basement membrane matrix (Matrigel; BD Biosciences, San Jose, CA) loaded with 9-cis retinal was administered subcutaneously into Rpe65(-/-) mouse pups for assessment of delivery to rods and cones and to Rpe65(-/-)Rho(-/-) mouse pups for assessment of delivery to cones. Intraperitoneal injections of 9-cis retinal were used for comparison. Cone density and opsin localization were evaluated with immunohistochemistry. Cone opsin protein levels were assayed with immunoblots, and cone function was analyzed by electroretinography (ERG) recordings. Retinoid content was determined by high-performance liquid chromatography analysis of retinal extracts. Pigment levels were quantified in homogenized retinas by absorption spectroscopy before and after light exposure. RESULTS: Single administration of Matrigel loaded with 9-cis retinal to Rpe65(-/-) mice increased cone densities in all analyzed regions of the retina compared with mice treated using intraperitoneal delivery. Cone opsin levels increased to near wild-type levels. Similar treatment in Rpe65(-/-)Rho(-/-) mice increased b-wave ERG amplitudes significantly, indicating the maintenance of cone function. Matrigel was shown to continuously release 9-cis retinal for periods up to 1 week. CONCLUSIONS: As a method for sustained drug delivery, subcutaneous administration using Matrigel proved more efficacious than intraperitoneal injection for in vivo delivery of retinoids to cone photoreceptors. These experiments are the first to show a sustained delivery of retinoids in mice and suggest a strategy for potential clinical therapeutic development.
PURPOSE: Delivery of hydrophobic compounds to the retina/RPE has been challenging. The purpose of this study was to develop an effective method for the sustained delivery of retinoids to rod and cone photoreceptors of young mice lacking a normal supply of 11-cis retinal. METHODS: Solubilized basement membrane matrix (Matrigel; BD Biosciences, San Jose, CA) loaded with 9-cis retinal was administered subcutaneously into Rpe65(-/-) mouse pups for assessment of delivery to rods and cones and to Rpe65(-/-)Rho(-/-) mouse pups for assessment of delivery to cones. Intraperitoneal injections of 9-cis retinal were used for comparison. Cone density and opsin localization were evaluated with immunohistochemistry. Cone opsin protein levels were assayed with immunoblots, and cone function was analyzed by electroretinography (ERG) recordings. Retinoid content was determined by high-performance liquid chromatography analysis of retinal extracts. Pigment levels were quantified in homogenized retinas by absorption spectroscopy before and after light exposure. RESULTS: Single administration of Matrigel loaded with 9-cis retinal to Rpe65(-/-) mice increased cone densities in all analyzed regions of the retina compared with mice treated using intraperitoneal delivery. Cone opsin levels increased to near wild-type levels. Similar treatment in Rpe65(-/-)Rho(-/-) mice increased b-wave ERG amplitudes significantly, indicating the maintenance of cone function. Matrigel was shown to continuously release 9-cis retinal for periods up to 1 week. CONCLUSIONS: As a method for sustained drug delivery, subcutaneous administration using Matrigel proved more efficacious than intraperitoneal injection for in vivo delivery of retinoids to cone photoreceptors. These experiments are the first to show a sustained delivery of retinoids in mice and suggest a strategy for potential clinical therapeutic development.
Authors: M L Applebury; M P Antoch; L C Baxter; L L Chun; J D Falk; F Farhangfar; K Kage; M G Krzystolik; L A Lyass; J T Robbins Journal: Neuron Date: 2000-09 Impact factor: 17.173
Authors: M W Seeliger; C Grimm; F Ståhlberg; C Friedburg; G Jaissle; E Zrenner; H Guo; C E Remé; P Humphries; F Hofmann; M Biel; R N Fariss; T M Redmond; A Wenzel Journal: Nat Genet Date: 2001-09 Impact factor: 38.330
Authors: J P Van Hooser; T S Aleman; Y G He; A V Cideciyan; V Kuksa; S J Pittler; E M Stone; S G Jacobson; K Palczewski Journal: Proc Natl Acad Sci U S A Date: 2000-07-18 Impact factor: 11.205
Authors: J Preston Van Hooser; Yan Liang; Tadao Maeda; Vladimir Kuksa; Geeng-Fu Jang; Yu-Guang He; Fred Rieke; Henry K W Fong; Peter B Detwiler; Krzysztof Palczewski Journal: J Biol Chem Date: 2002-03-15 Impact factor: 5.157
Authors: Jie Fan; Baerbel Rohrer; Jeanne M Frederick; Wolfgang Baehr; Rosalie K Crouch Journal: Invest Ophthalmol Vis Sci Date: 2008-02-22 Impact factor: 4.799
Authors: Alexander V Kolesnikov; Peter H Tang; Ryan O Parker; Rosalie K Crouch; Vladimir J Kefalov Journal: J Neurosci Date: 2011-05-25 Impact factor: 6.167
Authors: Bruce A Berkowitz; Timothy S Kern; David Bissig; Priya Patel; Ankit Bhatia; Vladimir J Kefalov; Robin Roberts Journal: Invest Ophthalmol Vis Sci Date: 2015-10 Impact factor: 4.799
Authors: Alexander V Kolesnikov; Akiko Maeda; Peter H Tang; Yoshikazu Imanishi; Krzysztof Palczewski; Vladimir J Kefalov Journal: J Physiol Date: 2015-10-18 Impact factor: 5.182
Authors: Ji-Young Kim; Hui Zhao; Jennifer Martinez; Teresa Ann Doggett; Alexander V Kolesnikov; Peter H Tang; Zsolt Ablonczy; Chi-Chao Chan; Zhenqing Zhou; Douglas R Green; Thomas A Ferguson Journal: Cell Date: 2013-07-18 Impact factor: 41.582